Drawing for MEDILYN

USPTO serial 79302425

MEDILYN

Reviewed by CopyMark Law Group

Reg. 6549721Status 700Renewal
Filing date
Status date
Registration date
Nov 9, 2021
Examiner
CAYCEDO, CATHERINE ANN
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with MEDILYN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
025non-medical gowns for nurses; uniforms; clothing, namely, shirts and pants; non-medical gowns for doctorsACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 28, 2025ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB
Apr 25, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED
Jan 30, 2025ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB
May 23, 2022FINOFINAL DECISION TRANSACTION PROCESSED BY IB
May 1, 2022FICSFINAL DISPOSITION NOTICE SENT TO IB
May 1, 2022FIMPFINAL DISPOSITION PROCESSED
Feb 9, 2022FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 9, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 24, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 24, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 21, 2021GPNXNOTIFICATION PROCESSED BY IB
Aug 4, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 4, 2021OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 4, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 21, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Jul 21, 2021XAECEXAMINER'S AMENDMENT ENTERED
Jul 21, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 21, 2021GNEAEXAMINERS AMENDMENT E-MAILED
Jul 21, 2021CNEAEXAMINERS AMENDMENT -WRITTEN
Jun 25, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Jun 24, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 24, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 4, 2021RFNTREFUSAL PROCESSED BY IB
Mar 16, 2021RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 16, 2021RFRRREFUSAL PROCESSED BY MPU
Mar 15, 2021RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 14, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 5, 2021DOCKASSIGNED TO EXAMINER
Jan 19, 2021MAFRAPPLICATION FILING RECEIPT MAILED
Jan 15, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 14, 2021SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Frequently asked questions

Related guidance